{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T17:46:09Z","timestamp":1745862369988},"reference-count":28,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2013]]},"DOI":"10.1536\/ihj.54.371","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T23:04:27Z","timestamp":1386025467000},"page":"371-376","source":"Crossref","is-referenced-by-count":2,"title":["Prophylactic Statin Administration May Prevent Shortening of the Fibrillation Cycle Length in Patients With New-Onset Atrial Fibrillation"],"prefix":"10.1536","volume":"54","author":[{"given":"Jun","family":"Oikawa","sequence":"first","affiliation":[{"name":"Department of Cardio-Angiology, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Niwano","sequence":"additional","affiliation":[{"name":"Department of Cardio-Angiology, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroe","family":"Niwano","sequence":"additional","affiliation":[{"name":"Department of Education, Tamagawa University, College of Education"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruya","family":"Ishizue","sequence":"additional","affiliation":[{"name":"Department of Cardio-Angiology, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Yoshizawa","sequence":"additional","affiliation":[{"name":"Department of Cardio-Angiology, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Cardio-Angiology, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Kurokawa","sequence":"additional","affiliation":[{"name":"Department of Cardio-Angiology, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hatakeyama","sequence":"additional","affiliation":[{"name":"Department of Cardio-Angiology, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehira","family":"Fukaya","sequence":"additional","affiliation":[{"name":"Department of Cardio-Angiology, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nattel S, Opie LH. Controversies in atrial fibrillation. Lancet 2006; 367: 262-72. (Review)","DOI":"10.1016\/S0140-6736(06)68037-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Suzuki S, Yamashita T, Ohtsuka T, <I>et al<\/I>. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008; 72: 914-20","DOI":"10.1253\/circj.72.914"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Inoue H, Fujiki A, Origasa H, <I>et al<\/I>. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 2009; 137: 102-7.","DOI":"10.1016\/j.ijcard.2008.06.029"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kumagai K, Nakashime H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003; 41: 2197-204.","DOI":"10.1016\/S0735-1097(03)00464-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101: 2612-7.","DOI":"10.1161\/01.CIR.101.22.2612"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shiroshita-Takeshita A, Brundel BJ, Burstein B, <I>et al<\/I>. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res 2007; 74: 75-84.","DOI":"10.1016\/j.cardiores.2007.01.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kumagai K, Nakashima H, Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004; 62: 105-11.","DOI":"10.1016\/j.cardiores.2004.01.018"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Patti G, Chello M, Candura D, <I>et al<\/I>. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114: 1455-61.","DOI":"10.1161\/CIRCULATIONAHA.106.621763"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Schneider MP, Hua TA, B&ouml;hm M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis. J Am Coll Cardiol 2010; 55: 2299-307. (Review)","DOI":"10.1016\/j.jacc.2010.01.043"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Liu T, Li L, Korantzopoulos P, Liu E, Li G. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol 2008; 126: 160-70. (Review)","DOI":"10.1016\/j.ijcard.2007.07.137"},{"key":"11","unstructured":"11. Husser D, Stridh M, Sornmol L, Olsson SB, Bollmann A. Frequency analysis of atrial fibrillation from the surface electrocardiogram. Indian Pacing Electrophysiol J 2004; 4: 122-36."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sasaki T, Niwano S, Sasaki S, <I>et al<\/I>. Long-term follow-up of changes in fibrillation waves in patients with persistent atrial fibrillation: spectral analysis of surface ECG. Circ J 2006; 70: 169-73.","DOI":"10.1253\/circj.70.169"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fujiki A, Nakagawa H, Sakabe M, <I>et al<\/I>. Spectral characteristics of human atrial fibrillation waves of the right atrial free wall with respect to the duration of atrial fibrillation and effect of class I antiarrhythmic drugs. Jpn Circ J 2001; 65: 1047-51.","DOI":"10.1253\/jcj.65.1047"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Niwano S, Sasaki T, Kurokawa S, <I>et al<\/I>. Predicting the efficacy of antiarrhythmic agents for interrupting persistent atrial fibrillation according to spectral analysis of the fibrillation waves on the surface ECG. Circ J 2009; 73: 1210-8.","DOI":"10.1253\/circj.CJ-08-1139"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fujiki A, Sakabe M, Nishida K, Mizumaki K, Inoue H. Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation. Circ J 2003; 67: 391-5.","DOI":"10.1253\/circj.67.391"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Newgard CD, Hedges JR, Arthur M, Mullins RJ. Advanced statistics: the propensity score -- a method for estimating treatment effect in observational research. Acad Emerg Med 2004; 11: 953-61.","DOI":"10.1111\/j.1553-2712.2004.tb00788.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002; 415: 219-26. (Review)","DOI":"10.1038\/415219a"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Neuberger HR, Schotten U, Blaauw Y, <I>et al<\/I>. Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. J Am Coll Cardiol 2006; 47: 644-53.","DOI":"10.1016\/j.jacc.2005.09.041"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Watanabe I, Okumura Y, Nagashima K, <I>et al<\/I>. Electrical remodeling in fibrillating canine atrium: action potential alternans during rapid atrial pacing and late phase 3 early afterdepolarization after cessation of rapid atrial pacing. Int Heart J 2010; 51: 354-8.","DOI":"10.1536\/ihj.51.354"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yokokawa M, Latchamsetty R, Good E, <I>et al<\/I>. The impact of age on the atrial substrate: insights from patients with a low scar burden undergoing catheter ablation of persistent atrial fibrillation. J Interv Card Electrophysiol 2012; 34: 287-94.","DOI":"10.1007\/s10840-011-9657-y"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chung MK, Martin DO, Sprecher D, <I>et al<\/I>. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-91.","DOI":"10.1161\/hc4901.101760"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Geo G, Dudley SC Jr. Redox regulation, NF-kappaB, and atrial fibrillation. Antioxid Redox Signal 2009; 11: 2265-77. (Review)","DOI":"10.1089\/ars.2009.2595"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 2004; 110: 2313-9.","DOI":"10.1161\/01.CIR.0000145163.56529.D1"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sacks FM. High-intensity statin treatment for coronary heart disease. JAMA 2004; 291: 1132-4.","DOI":"10.1001\/jama.291.9.1132"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ridker PM, Rifai N, Clearfield M, <I>et al<\/I>. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959-65.","DOI":"10.1056\/NEJM200106283442601"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Shishehbor MH, Brennan ML, Aviles RJ, <I>et al<\/I>. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 2003; 108: 426-31.","DOI":"10.1161\/01.CIR.0000080895.05158.8B"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ji Q, Mei Y, Wang X, <I>et al<\/I>. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J 2009; 73: 2244-9.","DOI":"10.1253\/circj.CJ-09-0352"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ozaydin M, Varol E, Aslan SM, <I>et al<\/I>. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol 2006; 97: 1490-3.","DOI":"10.1016\/j.amjcard.2005.11.082"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/54\/6\/54_371\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T07:27:24Z","timestamp":1618817244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/54\/6\/54_371\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.54.371","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}